Institutional Ownership
Nkgen Biotech Inc
CUSIP 65488A101COMNKGNQ1 2026
13D / 13G Filings
11
Schedule 13D/13G on record
Beneficial Filers
7
Distinct reporting persons
Largest Stake
63.4%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
11 filings · latest Jun 2, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jun 2, 2025 | Cfic-2015 NV Family Investments, LLC | 13D | 47.2% | — | SEC |
| 2 | May 15, 2025 | Meteora Capital, LLC | 13G/A | 6.1% | 2.76M | SEC |
| 3 | May 12, 2025 | Paul Y. Song | 13D | 54.3% | — | SEC |
| 4 | Feb 28, 2025 | Pathstone Family Office, LLC | 13G | 7.9% | 2.80M | SEC |
| 5 | Feb 14, 2025 | Meteora Capital, LLC | 13G/A | 7.8% | 2.77M | SEC |
| 6 | Aug 22, 2024 | Cfic-2015 NV Family Investments, LLC | 13G | 13.9% | 4.17M | SEC |
| 7 | May 10, 2024 | Meteora Capital, LLC | 13G/A | — | — | SEC |
| 8 | Feb 14, 2024 | Meteora Capital, LLC | 13G | 7.3% | 1.60M | SEC |
| 9 | Feb 7, 2024 | Adage Capital Partners Gp, L.L.C. | 13G/A | — | — | SEC |
| 10 | Dec 19, 2023 | Nkmax Co., Ltd. | 13D/A | 53.2% | 12.92M | SEC |
1 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Nkgen Biotech Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Meteora Capital, LLC | 2.76M | $192.9K |